FDA Outlines Regulatory Approach and Future Guidance for Generative AI Medical Devices
The U.S. Food and Drug Administration (FDA) is developing a regulatory blueprint for generative AI-enabled medical devices. This initiative includes considering physician-inspired evaluation methods and aims to release comprehensive guidance by 2027. The FDA's efforts signal a proactive approach to ensuring the safety and effectiveness of AI in healthcare.
3 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
2 outlets covered “FDA Outlines Regulatory Approach and Future Guidance for Generative AI Medical Devices”. All of them report the following:
- FDA is developing a regulatory framework for generative AI medical devices
- FDA is considering new evaluation methods, including a "doctor test" concept
- FDA plans to issue guidance on AI by 2027
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.